Adil Maarouf

Comparison of the Response to Rituximab between Myelin Oligodendrocyte Glycoprotein and Aquaporin‐4 Antibody Diseases

Pierre Durozard, Audrey Rico, Clémence Boutière et al. · Annals of Neurology · 2019 · 154 citations

Risk Factors and Time to Clinical Symptoms of Multiple Sclerosis Among Patients With Radiologically Isolated Syndrome

Christine Lebrun‐Frénay, Fabien Rollot, Lydiane Mondot et al. · JAMA Network Open · 2021 · 77 citations · Full text

Depletion of brain functional connectivity enhancement leads to disability progression in multiple sclerosis: A longitudinal resting-state fMRI study

Anthony Faivre, Emmanuelle Robinet, Maxime Guye et al. · Multiple Sclerosis Journal · 2016 · 74 citations

Extending rituximab dosing intervals in patients with MS during the COVID-19 pandemic and beyond?

Adil Maarouf, Audrey Rico, Clémence Boutière et al. · Neurology Neuroimmunology & Neuroinflammation · 2020 · 72 citations · Full text

MSCopilot, a new multiple sclerosis self‐assessment digital solution: results of a comparative study versus standard tests

Élisabeth Maillart, Pierre Labauge, Mikaël Cohen et al. · European Journal of Neurology · 2019 · 61 citations